Dysfunction of endothelial and smooth muscle cells in small arteries of a mouse model of Marfan syndrome

British Journal of Pharmacology

Volumn 158, Issue 6, 2009, Pages 1597-1608

  Syyong, H T ^a,b   Chung, A W Y ^b   Yang, H H C ^a,b   Van Breemen, C ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Elasticity; Endothelium dependent relaxation; Marfan syndrome; Mesenteric artery; Vascular smooth muscle

Indexed keywords

ACETYLCHOLINE; CATALASE; FIBRILLIN 1; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; POTASSIUM CHLORIDE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL STIFFNESS; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; HETEROZYGOSITY; MARFAN SYNDROME; MEMBRANE DEPOLARIZATION; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASODILATATION;

ACETYLCHOLINE; AGE FACTORS; ALLELES; ANIMALS; DISEASE MODELS, ANIMAL; ELASTICITY; ENDOTHELIUM, VASCULAR; MARFAN SYNDROME; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; MYOCYTES, SMOOTH MUSCLE; NITROPRUSSIDE; PHENYLEPHRINE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 70350545502     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00439.x     Document Type: Article

References (72)

1. Alvarez Y, Briones AM, Hernanz R, Perez-Giron JV, Alonso MJ, Salaices M (2008). Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats. Br J Pharmacol 153 : 926 935.
2. Boileau C, Jondeau G, Mizuguchi T, Matsumoto N (2005). Molecular genetics of Marfan syndrome. Curr Opin Cardiol 20 : 194 200.
3. Boutouyrie P, Bézie Y, Lacolley P, Challande P, Chamiot-Clerc P, Benetos A et al. (1997). In vivo/in vitro comparison of rat abdominal aorta wall viscosity. Influence of endothelial function. Arterioscler Thromb Vasc Biol 17 : 1346 1355.
4. Briones AM, González JM, Somoza B, Giraldo J, Daly CJ, Vila E et al. (2003). Role of elastin in spontaneously hypertensive rat small mesenteric artery remodelling. J Physiol 552 : 185 195.
5. Bulckaen H, Prévost G, Boulanger E, Robitaille G, Roquet V, Gaxatte C et al. (2008). Low-dose aspirin prevents age-related endothelial dysfunction in a mouse model of physiological aging. Am J Physiol Heart Circ Physiol 294 : H1562 70.
6. Bunton TE, Biery NJ, Myers L, Gayraud B, Ramirez F, Dietz HC (2001). Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome. Circ Res 88 : 37 43.
7. Cai H, Harrison DG (2000). Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 : 840 844.
8. Ceroni L, Ellis A, Wiehler WB, Jiang YF, Ding H, Triggle CR (2007). Calcium-activated potassium channel and connexin expression in small mesenteric arteries from eNOS-deficient (eNOS-/-) and eNOS-expressing (eNOS+/+) mice. Eur J Pharmacol 560 : 193 200.
9. Chew DK, Conte MS, Khalil RA (2004). Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction. J Vasc Surg 40 : 1001 1010.
10. Chung AW, Au Yeung K, Sandor GG, Judge DP, Dietz HC, van Breemen C (2007a). Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome. Circ Res 101 : 512 522.
11. Chung AW, Au Yeung K, Cortes SF, Sandor GG, Judge DP, Dietz HC et al. (2007b). Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome. Br J Pharmacol 150 : 1075 1083.
12. Chung AW, Yang HH, van Breemen C (2007c). Imbalanced synthesis of cyclooxygenase-derived thromboxane A2 and prostacyclin compromises vasomotor function of the thoracic aorta in Marfan syndrome. Br J Pharmacol 152 : 305 312.
13. Chung AW, Yang HH, Radomski MW, van Breemen C (2008). Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res 102 : e73 e85.
14. Corriu C, Félétou M, Puybasset L, Bea ML, Berdeaux A, Vanhoutte PM (1998). Endothelium-dependent hyperpolarization in isolated arteries taken from animals treated with NO-synthase inhibitors. J Cardiovasc Pharmacol 32 : 944 950.
15. Davis EC (1994). Immunolocalization of microfibril and microfibril-associated proteins in the subendothelial matrix of the developing mouse aorta. J Cell Sci 107 : 727 736.
16. Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM et al. (1991). Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352 : 337 339.
17. Dobrin PB (1978). Mechanical properties of arteries. Physiol Rev 58 : 397 460.
18. Donato AJ, Eskurza I, Silver AE, Levy AS, Pierce GL, Gates PE et al. (2007). Direct evidence of endothelial oxidative stress with aging in humans: Relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ Res 100 : 1659 1666.
19. Dora KA, Sandow SL, Gallagher NT, Takano H, Rummery NM, Hill CE et al. (2003). Myoendothelial gap junctions may provide the pathway for EDHF in mouse mesenteric artery. J Vasc Res 40 : 480 490.
20. Ellis A, Pannirselvam M, Anderson TJ, Triggle CR (2003). Catalase has negligible inhibitory effects on endothelium-dependent relaxations in mouse isolated aorta and small mesenteric artery. Br J Pharmacol 140 : 1193 1200.
21. Elmoselhi AB, Samson SE, Grover AK (1996). SR Ca2+ pump heterogeneity in coronary artery: Free radicals and IP3-sensitive and -insensitive pools. Am J Physiol 271 : C1652 C1659.
22. Faraci FM, Didion SP (2004). Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 24 : 1367 1373.
23. Gaubert ML, Sigaudo-Roussel D, Tartas M, Berrut G, Saumet JL, Fromy B (2007). Endothelium-derived hyperpolarizing factor as an in vivo back-up mechanism in the cutaneous microcirculation in old mice. J Physiol 585 : 617 626.
24. Gerhard M, Roddy MA, Creager SJ, Creager MA (1996). Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 27 : 849 853.
25. Giusti B, Porciani MC, Brunelli T, Evangelisti L, Fedi S, Gensini GF et al. (2003). Phenotypic variability of cardiovascular manifestations in Marfan syndrome. Possible role of hyperhomocysteinemia and C677T MTHFR gene polymorphism. Eur Heart J 24 : 2038 2045.
26. Goffi L, Chan R, Boccoli G, Ghiselli R, Saba V (2000). Aneurysm of a jejunal branch of the superior mesenteric artery in a patient with Marfan's syndrome. J Cardiovasc Surg 41 : 321 323.
27. González JM, Briones AM, Starcher B, Conde MV, Somoza B, Daly C et al. (2005). Influence of elastin on rat small artery mechanical properties. Exp Physiol 90 : 463 468.
28. Gray JR, Davies SJ (1996). Marfan syndrome. J Med Genet 33 : 403 408.
29. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK et al. (2006). Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312 : 117 121.
30. Hatrick AG, Malcolm PN, Burnand KG, Irvine AT (1998). A superficial femoral artery aneurysm in a patient with Marfan's syndrome. Eur J Vasc Endovasc Surg 15 : 459 460.
31. Jiang X, Yang F, Tan H, Liao D, Bryan RM Jr., Randhawa JK et al. (2005). Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol 25 : 2515 2521.
32. Jondeau G, Boutouyrie P, Lacolley P, Laloux B, Dubourg O, Bourdarias JP et al. (1999). Central pulse pressure is a major determinant of ascending aorta dilation in Marfan syndrome. Circulation 99 : 2677 2681.
33. Judge DP, Biery NJ, Keene DR, Geubtner J, Myers L, Huso DL et al. (2004). Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. J Clin Invest 114 : 172 181.
34. Judge DP, Dietz HC (2005). Marfan's syndrome. Lancet 366 : 1965 1976.
35. Kanie N, Kamata K (2000). Contractile responses in spontaneously diabetic mice. I. involvement of superoxide anion in enhanced contractile response of aorta to norepinephrine in C57BL/KsJ(db/db) mice. Gen Pharmacol 35 : 311 318. (Pubitemid 34258513)
36. Kielty CM, Wilson DG, Stuart G, Musumeci F, Cones CJ, Davies S et al. (1996). Fibrillin expression and deposition by vascular endothelial cells: implications for the Marfan syndrome. Circulation 94 : I-350.
37. Kilpatrick EV, Cocks TM (1994). Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery. Br J Pharmacol 112 : 557 565.
38. Laurant P, Adrian M, Berthelot A (2004). Effect of age on mechanical properties of rat mesenteric small arteries. Can J Physiol Pharmacol 82 : 269 275.
39. Lay CS, Yu CJ, Tyan YS (2006). Abdominal aortic dissection with acute mesenteric ischemia in a patient with Marfan syndrome. J Chin Med Assoc 69 : 326 329.
40. Lounsbury KM, Hu Q, Ziegelstein RC (2000). Calcium signaling and oxidant stress in the vasculature. Free Radic Biol Med 28 : 1362 1369.
41. Lyle AN, Griendling KK (2006). Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 21 : 269 280.
42. McCulloch AI, Bottrill FE, Randall MD, Hiley CR (1997). Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br J Pharmacol 120 : 1431 1438.
43. McGuire JJ, Hollenberg MD, Andrade-Gordon P, Triggle CR (2002). Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles. Br J Pharmacol 135 : 155 169.
44. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K et al. (2000). Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 106 : 1521 1530.
45. Milnor WR (1989). Properties of the vascular wall. In : Collins N (ed.). Hemodynamics. Williams & Wilkins : Baltimore, pp. 84 90.
46. Mulvany MJ, Aalkjaer C (1990). Structure and function of small arteries. Physiol Rev 70 : 921 961.
47. Murdoch JL, Walker BA, Halpern BL, Kuzma JW, McKusick VA (1972). Life expectancy and causes of death in the Marfan syndrome. N Engl J Med 286 : 804 808.
48. Nakamura M, Itoh S, Makita S, Ohira A, Arakawa N, Hiramori K (2000). Peripheral resistance vessel dysfunction in Marfan syndrome. Am Heart J 139 : 661 666.
49. Newaz MA, Yousefipour Z, Oyekan A (2006). Oxidative stress-associated vascular aging is xanthine oxidase-dependent but not NAD(P)H oxidase-dependent. J Cardiovasc Pharmacol 48 : 88 94.
50. Ng CM, Cheng A, Myers LA, Martinez-Murillo F, Jie C, Bedja D et al. (2004). TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 114 : 1586 1592.
51. Nishikawa Y, Stepp DW, Chilian WM (2000). Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol Heart Circ Physiol 279 : H459 H465.
52. Ohba M, Shibanuma M, Kuroki T, Nose K (1994). Production of hydrogen peroxide by transforming growth factor-beta1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J Cell Biol 126 : 1079 1088.
53. Peng X, Haldar S, Deshpande S, Irani K, Kass DA (2003). Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium. Hypertension 41 : 378 381.
54. Pyeritz RE (2000). The Marfan syndrome. Annu Rev Med 51 : 481 510.
55. Ramsey MW, Goodfellow J, Jones CJ, Luddington LA, Lewis MJ, Henderson AH (1995). Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation 92 : 3212 3219.
56. Reinhardt DP, Chalberg SC, Sakai LY (1995). The structure and function of fibrillin. Ciba Found Symp 192 : 128 143.
57. Rembold CM, Murphy RA (1990). Muscle length, shortening, myoplasmic [Ca2+], and activation of arterial smooth muscle. Circ Res 66 : 1354 1361.
58. Rosenbloom J (1993). Extracellular matrix 4: the elastic fiber. FASEB J 7 : 1208 1218.
59. Safar ME, London GM (1994). The arterial system in human hypertension. In : Swales JD (ed.). Textbook of Hypertension. London : Blackwell Scientific Publications, pp. 85 102.
60. Savolainen H, Savola J, Savolainen A (1993). Aneurysm of the iliac artery in Marfan's syndrome. Ann Chir Gynaecol. 82 : 203 205.
61. Schulz E, Anter E, Keaney JF Jr. (2004). Oxidative stress, antioxidants, and endothelial function. Curr Med Chem 11 : 1093 1104.
62. Sener G, Paskaloglu K, Toklu H, Kapucu C, Ayanoglu-Dulger G, Kacmaz A et al. (2004). Melatonin ameliorates chronic renal failure-induced oxidative organ damage in rats. J Pineal Res 36 : 232 241. (Pubitemid 38530470)
63. Sheremet'eva GF, Ivanova AG, IuV B, Gens AP, Kocharian EZ (2004). A comparative study of the aortic wall in patients with Marfan's syndrome and Erdheim's disease. Angiol Sosud Khir 10 : 22 29.
64. Shimokawa H (1999). Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol 31 : 23 37.
65. Smith WL, DeWitt DL, Garavito RM (2000). Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69 : 145 182.
66. Tare M, Coleman HA, Parkington HC (2002). Glycyrrhetinic derivatives inhibit hyperpolarization in endothelial cells of guinea pig and rat arteries. Am J Physiol Heart Circ Physiol 282 : H335 H341.
67. Vanhoutte PM (2004). Endothelium-dependent hyperpolarizations: the history. Pharmacol Res 49 : 503 508.
68. Vitarelli A, Conde Y, Cimino E, D'Angeli I, D'Orazio S, Stellato S et al. (2006). Aortic wall mechanics in the Marfan syndrome assessed by transesophageal tissue Doppler echocardiography. Am J Cardiol 97 : 571 577.
69. Walia M, Sormaz L, Samson SE, Lee RM, Grover AK (2000). Effects of hydrogen peroxide on pig coronary artery endothelium. Eur J Pharmacol 400 : 249 253.
70. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AP, Cockcroft JR (2002). Nitric oxide regulates local arterial distensibility in vivo. Circulation 105 : 213 217.
71. Williams A, Davies S, Stuart AG, Wilson DG, Fraser AG (2008). Medical treatment of marfan syndrome: a time for change. Heart 94 : 414 421.
72. Wilson DG, Bellamy MF, Ramsey MW, Goodfellow J, Brownlee M, Davies S et al. (1999). Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilation. Circulation 99 : 909 915.